|
⚲
|
| Keyboard |
| Techne Corp /MN/ | |
|---|---|
| Ticker | TECH |
| CIK # | 0000842023 |
| CUSIP | 878377100 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 614 Mckinley Pl N E, Minneapolis, MN 55413 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0000842023] | 10-K | |
| [0000842023] | 10-Q | |
| [0000842023] | 3 | |
| [0000842023] | 4 | |
| [0000842023] | 8-K | |
| [0000842023] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| FMR LLC | Bio-Techne Corp | [2026-05-06] | 0.0 |
| Vanguard Capital Management LLC | Bio-Techne Corp | [2026-04-29] | 0.0 |
| Price T Rowe Associates Inc /MD/ | Bio-Techne Corp | [2024-11-14] | 5.9 |
| BlackRock Inc | Bio-Techne Corp | [2023-01-20] | 10.1 |
| Eaton Vance Management | Bio-Techne Corp | [2018-02-14] | 5.42 |
| Select Equity Group LP | Bio-Techne Corp | [2017-02-13] | 6.3 |
| Brown Capital Management LLC | Techne Corp /MN/ | [2013-11-07] | 5.19 |
| Vanguard Group Inc | Techne Corp /MN/ | [2013-02-11] | 5.16 |
| Techne Corp /MN/ | ChemoCentryx Inc | [2012-02-16] | 18.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crouse Steven C
Stock Option (right to buy) · derivative
|
2026-03-02 | Grant | 1,911 | $0.00 | |
|
Crouse Steven C
Restricted Stock Units · derivative
|
2026-03-02 | Grant | 735 | $0.00 | |
|
Crouse Steven C
Performance Restricted Stock Units · derivative
|
2026-03-02 | Grant | 2,387 | $0.00 | |
|
Herr Amy E
Common Stock
|
2026-02-17 | Sell | 1,976 | $59.11 | 116,801 |
|
Herr Amy E
Common Stock
|
2026-02-03 | Option exercise | 38 | $0.00 | |
|
Herr Amy E
Restricted Stock Units · derivative
|
2026-02-03 | Option exercise | 38 | $0.00 | |
|
Herr Amy E
Common Stock
|
2026-02-03 | Tax withheld | 16 | $64.63 | 1,034 |
|
McManus Matthew
Common Stock
|
2026-02-01 | Tax withheld | 1,665 | $64.09 | 106,710 |
|
McManus Matthew
Common Stock
|
2026-02-01 | Option exercise | 4,621 | $0.00 | |
|
McManus Matthew
Restricted Stock Units · derivative
|
2026-02-01 | Option exercise | 4,621 | $0.00 | |
|
Geist William
Restricted Stock Units · derivative
|
2025-11-03 | Option exercise | 9,911 | $0.00 | |
|
Hippel James
Restricted Stock Units · derivative
|
2025-11-03 | Option exercise | 11,545 | $0.00 | |
|
Hippel James
Common Stock
|
2025-11-03 | Option exercise | 11,545 | $0.00 | |
|
Hippel James
Common Stock
|
2025-11-03 | Option exercise | 13,159 | $0.00 | |
|
Hippel James
Restricted Stock Units · derivative
|
2025-11-03 | Option exercise | 13,159 | $0.00 | |
|
Geist William
Common Stock
|
2025-11-03 | Tax withheld | 4,520 | $62.57 | 282,816 |
|
Hippel James
Common Stock
|
2025-11-03 | Tax withheld | 11,865 | $62.57 | 742,393 |
|
Kelderman Kim
Common Stock
|
2025-11-03 | Tax withheld | 2,303 | $62.57 | 144,099 |
|
Geist William
Common Stock
|
2025-11-03 | Option exercise | 9,911 | $0.00 | |
|
Seth Alpna
Stock Options (Right to Buy) · derivative
|
2025-10-30 | Grant | 3,777 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 584 | 173,472,029 |
| 2025-12-31 | 586 | 167,147,015 |
| 2025-09-30 | 581 | 154,878,294 |
| 2025-06-30 | 556 | 148,358,108 |
| 2025-03-31 | 580 | 150,625,640 |
| 2024-12-31 | 577 | 150,676,846 |
| 2024-09-30 | 566 | 144,610,075 |
| 2024-06-30 | 574 | 146,757,806 |
| 2024-03-31 | 558 | 160,924,763 |
| 2023-12-31 | 537 | 155,194,144 |
| 2023-09-30 | 530 | 146,518,603 |
| 2023-06-30 | 530 | 145,172,194 |